Выпуск
Breaking Barriers to Better Hearts: Optimizing LDL-C Management for Cardiovascular Risk Reduction
CME Outfitters Medical Education · 10 июля 2026 г. · 1 ч 0 мин
Despite advances in the prevention and management of atherosclerotic cardiovascular disease (ASCVD), gaps remain in real-world risk assessment and lipid-lowering treatment, particularly among intermediate- and high-risk patients. Inconsistent use of risk assessment tools, variable evaluation of risk-enhancing factors, and suboptimal initiation or intensification of lipid-lowering therapies contribute to therapeutic inertia and prevent many patients from achieving recommended low-density lipoprotein cholesterol (LDL-C) targets. These challenges are compounded by evolving guidelines, increasing treatment complexity, and the expanding availability of non-statin therapies. Targeted education is essential to improve clinicians’ ability to apply current guidelines, prioritize LDL-C goal attainment, and implement evidence-based strategies—including add-on therapies and shared decision-making—to optimize care and reduce cardiovascular risk. In this CME Outfitters recorded webcast, expert faculty will review current ASCVD risk assessment guidelines, highlight the importance of achieving recommended LDL-C targets in intermediate- and high-risk patients, and discuss practical strategies to optimize therapeutic decision-making in clinical practice. Learn More Here